1 / 49

FDA - INTRODUCTION TO DRUG REGULATION

FDA - INTRODUCTION TO DRUG REGULATION. Edward P. Richards Director, Program in Law, Science, and Public Health Louisiana State University Law Center http://biotech.law.lsu.edu. Basic Mission. Safety Efficacy Drugs Medical Devices Truthful Labeling Adulteration Misbranding.

daphner
Download Presentation

FDA - INTRODUCTION TO DRUG REGULATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. FDA - INTRODUCTION TO DRUG REGULATION Edward P. Richards Director, Program in Law, Science, and Public Health Louisiana State University Law Center http://biotech.law.lsu.edu

  2. Basic Mission • Safety • Efficacy • Drugs • Medical Devices • Truthful Labeling • Adulteration • Misbranding

  3. FDA's Structure and Organization • The Commissioner • President Appoints, Senate Confirms • 4th Tier in HHS • Not an Independent Agency • Insulation From Politics (Old Days) • Few Political Appointees • Scientific Basis of Its Decisions • Visibility Protects It From Presidential Pressure

  4. Does Congress Defer to the FDA? • No, Congress Constantly Reviews the Agency in Committee Meetings • Why? • Lots of Money • Lots of Powerful Interests • Drugs, Food Labeling • Food and Drug Cranks

  5. Political Control - Food Supplements • Did Regulate Food Supplements and “Health Foods” • Began to Crack Down on Unproven Claims and Raise Questions about Safety • Congress was Lobbied (Oren Hatch) • Pulled the FDA Authority to Regulate Food Supplements • Can Only Act on Evidence of Post-Marketing Harm • No Pre-Market Approval

  6. What Does the FDA Regulate? • Food (with Agriculture Department) • Drugs • Biologics • Medical Devices • Cosmetics • Anything That Produces Dangerous Radiation • 25% of the Consumer Dollar

  7. What Is a Drug? 201(g) • (A) Articles Recognized in the Official United States Pharmacopoeia, Official Homeopathic Pharmacopoeia of the United States, or Official National Formulary, or Any Supplement to Any of Them • Does the FDA Really Treat Every Thing in These As Drugs?

  8. What Is a Drug? 201(g) • (B) Articles Intended for Use in the Diagnosis, Cure, Mitigation, Treatment, or Prevention of Disease in Man or Other Animals • How Do You Judge This? • Manufacturer or Seller's Representations • Are These Limited to Labels and Advertising? • No, Sec Info Is an Example • Can Consider Consumer Expectations in Exceptional Circumstances

  9. What Is a Drug? 201(g) • (C) Articles (Other Than Food) Intended to Affect the Structure or Any Function of the Body of Man or Other Animals • Do They Really Mean This? (Guns, Bullets) • (D) Articles Intended for Use As a Component of Any Article Specified in Clauses (A), (B), or (C) of This Paragraph.

  10. Prescription Drug Regulation • Good Old Days • In the Early 1900s You Could Get Anything You Wanted • No Concern for People Poisoning Themselves • Few Effective Drugs • Limited Rationale for Physician Supervision • Harrison Narcotics Act • Heroin Was the Hero Drug Because It Saved People From Morphine

  11. Getting a Drug Approved • Isolate or Synthesize the Agent • Many are Biologicals • Cyclosporin • Tamoxifen • Structure Activity Design • Genetic Engineering • Do Animal or in Vitro Studies to Determine Activity • Apply for an Investigational New Drug (Ind) Permit

  12. Requirements for Approval for Sale in Interstate Commerce • Safe • As compared to what? • How is this relative to the underlying condition being treated? • Effective • How effective? • Compared to placebo? • Compared to other drugs?

  13. Submit for FDA Approval • Clinical Trials Can Take Years • Very Expensive >>$200,000,000 • Most Drugs are Not Approved • Labeling is Key to Approval • Narrow Use allows More Dangerous Drugs • Broader Use Means More Money

  14. Clinical Trials • Phase I • What are the side effects? • Is it safe enough to test? • Phase II • Does it work at all? • What is the dosage range? • Phase III • Is it better than placebo? • Is it better than other treatments? • What are the side-effects

  15. Conflicts in Clinical Trials • Life Saving Drugs • Patients want a cure • Drugs probably do not work • What if the drug is available outside the trial? • Do you quit a drug that works to get on the trial? • What if the patient Lies? • Non-Life Saving Drugs • Pay the subjects? • Docs get paid by the patient • Companies want positive results

  16. The Drug Lag • What Is the Drug Lag? • What Are the Conflicts? • FDA Risk Aversion? • Freedom of Choice? • What Are the Conflicting Expectations That the FDA Faces?

  17. Sources of Law on Drug Labels • Federal Trade Commission • FDA • State Deceptive Trade Practices Laws • State Tort Laws • No FDA preemption of state requirments

  18. Why Is Labeling So Important? • All Drugs Pose Risks • Inherent Risks • Risks Due To Interactions With Other Drugs • Risks Due To Disease States • Risk Of Over and Under Dosage • NO RISKS ARE OBVIOUS!

  19. Manufacturers Have The Most Information • Clinical Trials Under The IND • Proprietary Information • Controlled By The Manufacturer • Should Be Reported To The FDA • Post-Market Information • Manufacturer Gets Primary Reports • Should Pass Information To The FDA

  20. What is a Label - I • "Brochures, booklets, mailing pieces, detailing pieces, file cards, bulletins, calendars, price lists, catalogs, house organs, letters, motion picture films, film strips, lantern slides, sound recordings, exhibits, literature, and reprints and similar pieces of printed, audio or visual matter descriptive of a drug and references published (for example, the Physician's Desk Reference)

  21. What is a Label - II • for use by medical practitioners, pharmacists, or nurses, containing drug information supplied by the manufacturer, packer, or distributor of the drug and which are disseminated by or on behalf of its manufacturer, packer, or distributor are hereby determined to be labeling as defined in section 201(m) of the FD&C Act."

  22. Rx Drugs • Physician Information • Package Insert • Information Sheets For Physicians • Depends on Expertise of Physician • What about non-physician prescribers? • Rarely, Patient Package Insert • When Patients Have Significant Control Over Choice of Drugs • Birth Control Pills

  23. OTC • On The Box • Insert In The Box • Must Allow Safe Use By Consumer • Labeling Issues Often Determine Whether A Drug Is OTC or Rx

  24. Labels Can Make The Drug • Apple Cider Vinegar Alone is not a Drug • Apple Cider Vinegar with a Label that Says It Will Cure Cancer is a Drug, Subject to FDA Regulation • Also Subject to FTC Regulation • Does a Book Saying it Treats Cancer Make it a Drug? • Is the Author Guilty of Misrepresentation?

  25. FDA Standards for Labels • A Drug is Misbranded If: • [Its] "labeling is false or misleading in any particular" or • the labeling does not bear "adequate directions for use." • Drugs are Misbranded if the Manufacturer Does Not Use the FDA Approved Label Information • Misbranded Products Cannot Be Sold

  26. Federal Trade Commission Standards for Labels • Misleading Or Deceptive • FTC Looks At All Advertising And Promotional Materials • Penalties • Civil Fines • Criminal Prosecution • Usually Secondary To The FDA For Drugs • Governs Medical Products That Are Not Under the FDCA

  27. Tort Law Standards for Labels • Must Provide Full Prescribing Information • Must Provide All Side-effects and Contraindications • Must Anticipate Misuse and Warn Against it • Must Quickly Add Any New Information about the Drug

  28. What the Label Cannot Have • Unapproved Uses • Only Uses From Approved NDAs • Hence "Off-Label" Uses • Disputes with the FDA • No Over-Warning • CYA in Tort Cases • Interferes with Rational Prescribing

  29. Patient Package Inserts • Legal Authority To Require? • Regulatory History • Why Did Physicians Oppose Them? • What Drugs Must Have Them Now? • Why Is The FDA Interested In Them Again?

  30. Promotional Materials • Real Issues • Off Label Uses • Inappropriate Use • FDA Authority Over Promotional Materials • Can The FDA Control What Detailmen Say? • How Have Companies Gotten In Trouble?

  31. Providing Information On Unapproved Uses • The Manufacturer Cannot Advertise Unapproved Uses • The Manufacturer Can Send Out Medical Journal Reprints On Unapproved Uses • Must Log and Notify FDA • May Have to Retract if the Science Changes • Must A Manufacturer Warn Against Known Unapproved Uses?

  32. Requirements for Direct to Consumer Ads • All the contraindications • All the warnings • All the major precautions • All other frequently occurring side effects that are likely to be drug-related • Include Contact Phone and URL

  33. Internet Information • WWW Pages are Subject To FDA Regulation • Non-Manufacturer Sites • Can Pharmacies Tout Unapproved Uses? • What about Access to Rx Drugs without an Rx? • Can Manufacturers Link To Non-Manufacturer Sites?

  34. Direct to Patient Marketing and OTC Switch • Are the Vast Majority of People Prepared for Self-medication? • What Is the Products Liability Problem? • Labels for Idiots • Social Policy for Communicable Diseases? • Defeats the Reporting System • Improper Antibiotics Use Leads to Drug-resistant Infections

  35. Tort Implications of Direct Advertising • Undermines Learned Intermediary Defense • Can Trigger a Duty to Warn the Patients Directly • Makes Rx Drugs More Like OTC • Must the FDA Approve a Voluntary PPI?

  36. Future Issue • Commercial Speech Restrictions On FDA Authority • Blurring of OTC And RX Labeling Because Of Internet Sales • Shifting Of Warning Duties To Pharmicists • Changing Labeling Standards As States License Non-Physician Prescribers

  37. Controlled Substances • Drug Enforcement Administration (DEA) • What Are the 5 Schedules? • I High Potential for Abuse and No Currently Accepted Medical Use (in the Us) - Heroin • II High Potential for Abuse but a Medical Use • III Moderate Potential for Abuse • IV Low Potential for Abuse • V Lowest Potential for Abuse • Constitutional Right to Do Dope?

  38. Post-Market Surveillance - The Vioxx Question • Clinical Trials Are Limited in Time and Scope • Many Serious Side-effects Cannot be Detected in Trials • Dangerous to Include Pregnant Women, so no tetragons are detected • Docs are Supposed to Report Side-effects • Not always very effective • Large Scale Trials Should Continue • Who will fund them? • Drug Companies do not want to undermine their products

  39. History of Drug Liability • FDA History is the History of Drug Injuries • FDA Regulation Tries to Prevent Future Injuries • Tort Litigation Compensates for Past Injuries

  40. Multiple Sovereigns • Tort Law for Drugs is State Law • Basic Theories are the Same • Significant Variation on Details • Federal Courts Apply State Law • Individual Judges Have Great Discretion • Many Case Depend on Whether the Judge Admits the Plaintiff's Evidence • Forum Shopping

  41. Negligence • Traditional Cases Were Usually Based in Negligence • Had to Show Legal Relationship – Privity • No Relationship Between Patient and Drug Company • Ended with Pharmacist • Made Sense when Pharmacists Compounded all the Drugs

  42. Fall of Privity • Courts Found Privity Out of Date with the Industrial Revolution • Thomas v. Winchester (1852) • Supplier Provided Belladonna rather than Dandelion • Privity would have Blocked the Claim • Court Limited Privity for Dangerous Activities

  43. Early Strict Liability • Many States Imposed Strict Liability for Ultrahazardous Activities • Blasting • Impounding Water • Plaintiff did not need to Show Negligence, only Injury Due to the Activity • Very Limited Application – not generally extended to Drugs

  44. Limits of Negligence • Must Show Breach of Standard of Care • What a Reasonable Manufacturer Would Do? • Only Evidence is Other Manufacturers • Must Show What Happened to the Specific Batch

  45. Warranty Theories • Predate Strict Liability • Related to UCC Warranties • Cannot Disclaim for Personal Injuries • Based on Promises • Special Problem for Promoting Off-Label Uses

  46. Express Warranty • Manufacturer Is Held to Specific Promises • Shatterproof Windshield Case • Claimed It Was Just “Puffing” • Court Said It Was a Clear Promise • Did Not Matter If It Was Impossible • Can Be Written or Verbal • Can Physicians Give Binding Warranties About Products?

  47. Implied Warranties • Implied From the Context of the Sale • A Product Is Safe for What It Is Sold for • FDA Approved Drugs Have Only the Stated Risks • Implied Warranty of Fitness for a Specific Purpose • Manufacturer or Seller Says the Product Is Good for Something Other Than Its Usual Purpose • Use of Drugs For Unapproved Purposes

  48. Jeep Case • Jeep Sold for off the Road Use • Rolled and Killed and Injured Passengers • Made Like a Sardine Can • Manufacturer Claimed Improper Use • How Do You Prove? • Advertising • Representations by Sales Persons

  49. Shift to Strict Liability • Hard to Prove Negligence for Products • Generic Goods - No Specific Information • Defendant’s Have Lots of Resources • Defects Affect Lots of People • Strict Liability Encourages Safety • Cannot Escape Liability by Just Doing What Others Do • Safer Products = Lower Costs

More Related